Rankings
▼
Calendar
BVS FY 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$431M
+34.2% YoY
Gross Profit
$303M
70.3% margin
Operating Income
$12M
2.8% margin
Net Income
$19M
4.5% margin
EPS (Diluted)
$-0.15
Cash Flow
Operating Cash Flow
$23M
Free Cash Flow
$2M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$692M
Stockholders' Equity
$459M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$431M
$321M
+34.2%
Gross Profit
$303M
$234M
+29.6%
Operating Income
$12M
$21M
-43.2%
Net Income
$19M
$16M
+18.1%
← Q4 2020
All Quarters
Q1 2021 →